User:Maxthibert/sandbox

Nick Arjomand, born October 1, 2003, is an entrepreneur and founder of SimpliGene, the world's first affordable non-invasive cancer screening method using bi-product mutations to detect cancer development. Arjomand was born in Santa Monica, California, and currently attends Crossroads School for the Arts and Sciences. Nick started SimpliGene in 2017 as a method to discover lung cancer, but soon expanded his focus to all forms of cancer.